Salibay, Baby Girl .
HRN: 26-64-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/06/2025
02/13/2025
INTRAVENOUS
8 Mg
Every 36 Hours
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes